“…To discover small molecule agonists for DrmSPR, a compound library based on a pyrazolodiazepine scaffold, previously reported as a potential privileged structure, was screened. Structure-activity relationship studies of the hit compounds, were explored through analog synthesis resulting in 6-benzyl pyrazolodiazepine derivatives found to be small molecule agonists for DrmSPR [16].…”